Search results

• Croda acquired crop enhancement company Plant Impact

  Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Croda acquires marine biotechnology specialists Nautilus

  World class scientists, focusing on using marine microbial biodiversity to discover novel actives and materials for applications across all Croda market sectors.

• Croda acquires Inventiva, encapsulation and delivery system technology

  It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.

• Croda acquires research enterprise Enza Biotech

  Developing the next generation of renewable surfactants using carbohydrate-based chemistry.

• Croda expands Iberchems fragrances offering with the acquisition of Parfex

  Croda has acquired a controlling majority 95.6% of Parfex’s outstanding shares, comprising the founding shareholders and certain minority investors.

• Acquisition of Alban Muller

  The acquisition expands Croda’s portfolio of sustainable active ingredients for customers in personal care markets.

• Croda acquires innovative seed enhancement company Incotec

  Operating in one of the fastest growing segments within the crop care market, Incotec develop and supply a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops.

• Acquisition of Iberchem expands reach into high growth fragrances market

  Acquiring the entire issued share capital of Fragrance Spanish Topco, S.L., trading as Iberchem (“the acquisition”), a leading global fragrances and flavours (“F&F”) company.

• Strengthening Life Sciences with the acquisition of Avanti Polar Lipids

  A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.

• Strategic investment Entekno Materials

  A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Vietnam

  Croda’s Vietnam office was founded in 2012 and is located in Ho Chi Minh City.

• Celebrating a century of Croda

  Croda marks 100 years with global celebrations highlighting our people, history, and commitment to our Purpose: Smart science to improve lives™.

• UK Pensions

  Explore information on Croda UK pensions, including state pensions, workplace schemes, death benefits and retirement.

• Mexico

  In 1977, a joint venture company was formed in Mexico, Quimica Croda SA.

• Singapore

  Croda Singapore was founded in 1986 and is the regional headquarters of the Asia Pacific region.

• Externally validated avoided emissions

  The emissions savings of this new product were revealed during its sustainability assessment, part of the new way of working for our innovation teams to support our Commitment.

• Finance review 2025

  “With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”

• North America

  Croda Inc is the North American headquarters for Croda, we have four manufacturing sites, four innovation centres and four sales hubs in the region.